Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
40.17B | 38.69B | 37.84B | 34.22B | 33.75B | 27.75B | Gross Profit |
11.44B | 11.72B | 11.82B | 10.81B | 10.72B | 8.49B | EBIT |
2.00B | 2.45B | 3.33B | 3.22B | 3.55B | 2.30B | EBITDA |
2.69B | 3.30B | 4.05B | 3.86B | 4.13B | 2.81B | Net Income Common Stockholders |
1.34B | 1.66B | 2.42B | 2.40B | 2.66B | 1.71B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
537.28M | 537.28M | 381.58M | 344.83M | 1.38B | 240.32M | Total Assets |
30.80B | 30.80B | 29.08B | 26.33B | 25.86B | 22.83B | Total Debt |
18.09B | 18.09B | 17.66B | 14.25B | 13.59B | 11.70B | Net Debt |
17.55B | 17.55B | 17.28B | 13.90B | 12.21B | 11.46B | Total Liabilities |
24.05B | 24.05B | 23.54B | 20.07B | 19.20B | 16.12B | Stockholders Equity |
6.75B | 6.75B | 5.54B | 6.26B | 6.66B | 6.70B |
Cash Flow | Free Cash Flow | ||||
1.65B | 691.58M | 423.97M | 1.80B | 2.85B | 1.45B | Operating Cash Flow |
3.14B | 2.39B | 1.98B | 2.87B | 3.88B | 2.24B | Investing Cash Flow |
-1.49B | -1.69B | -1.56B | -1.07B | -1.02B | -782.49M | Financing Cash Flow |
-1.48B | -542.07M | -392.46M | -2.83B | -1.71B | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $460.27B | 60.89 | 30.98% | 0.44% | 5.35% | 16.22% | |
73 Outperform | $4.78B | 17.36 | 16.61% | ― | 14.32% | 0.02% | |
73 Outperform | $13.38B | 23.88 | 31.64% | ― | 5.32% | 10.61% | |
72 Outperform | $6.34B | 30.85 | 12.84% | ― | 12.48% | 32.49% | |
68 Neutral | $15.81B | 11.84 | 18.19% | 3.28% | 2.90% | -30.27% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% | |
56 Neutral | $15.67B | ― | -13.67% | ― | 5.19% | -190.36% |